ArticleBreast cancer research and treatment2024

Analysis of data from the PALOMA-3 trial confirms the efficacy of palbociclib and offers alternatives for novel assessment of clinical trials.

Celine Yeh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.